Folic acid supplement
First Claim
Patent Images
1. A nutritional supplement for optimizing absorption of folic acid in an animal, which consists essentially of:
- a stable chewable, dissolvable form comprising a non-toxic acid neutralizing alkaline compound combined with a folic acid compound or derivative thereof;
wherein the non-toxic acid neutralizing alkaline compound has a total daily dosage of at least 2 meq of acid neutralizing capacity, and the folic acid compound or derivative thereof has a total daily dosage of at least 450 mcg.
17 Assignments
0 Petitions
Accused Products
Abstract
The present invention is directed to novel chewable or dissolvable nutritional supplements for improving the absorption of folic acid in humans and other animals and methods of using said supplements. The nutritional supplements contain folic acid and non-toxic acid neutralizing alkaline compounds in chewable or dissolvable forms.
-
Citations
48 Claims
-
1. A nutritional supplement for optimizing absorption of folic acid in an animal, which consists essentially of:
-
a stable chewable, dissolvable form comprising a non-toxic acid neutralizing alkaline compound combined with a folic acid compound or derivative thereof;
wherein the non-toxic acid neutralizing alkaline compound has a total daily dosage of at least 2 meq of acid neutralizing capacity, and the folic acid compound or derivative thereof has a total daily dosage of at least 450 mcg. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8)
-
-
9. A nutritional supplement for optimizing absorption of a folic acid compound or derivative thereof in an animal, which consists essentially of:
-
a stable chewable, dissolvable form comprising a non-toxic acid neutralizing alkaline compound surrounding a folic acid compound or derivative thereof;
wherein the non-toxic acid neutralizing alkaline compound has a total daily dosage of at least 2 meq of acid neutralizing capacity, and the folic acid compound or derivative thereof has a total daily dosage of at least 450 mcg. - View Dependent Claims (10, 11, 12, 13, 14, 15)
-
-
16. A prenatal nutritional supplement for optimizing absorption of folic acid in a pregnant woman, which consists essentially of:
-
a stable chewable, dissolvable form comprising a non-toxic acid neutralizing alkaline compound surrounding a folic acid compound or derivative thereof;
wherein the non-toxic acid neutralizing alkaline compound has a total daily dosage of at least 2 meq of acid neutralizing capacity, and the folic acid compound or derivative thereof has a total daily dosage of at least 500 mcg.
-
-
17. A method for optimizing absorption of folic acid in a pregnant woman, which comprises ingesting:
-
stable chewable, dissolvable dosage form comprising a non-toxic acid neutralizing alkaline compound surrounding a folic acid compound or derivative thereof;
wherein the non-toxic acid neutralizing alkaline compound is present in said dosage form in a total daily dosage of at least 2 meq of acid neutralizing capacity, and the folic acid compound or derivative thereof is present in said dosage form in a total daily dosage of at least 450 mcg. - View Dependent Claims (18, 19, 20, 21, 22, 23)
-
-
24. A prenatal chewable nutritional supplement for optimizing absorption of folic acid in a pregnant woman, which consists essentially of:
-
a stable chewable form comprising a non-toxic acid neutralizing alkaline compound selected from the group consisting of calcium-based compounds, antacids, aluminum-based compounds, magnesium-based compounds, sodium-based compounds, potassium-based compounds, and mixtures thereof surrounding a folic acid compound or derivative thereof;
wherein the non-toxic acid neutralizing alkaline compound has a total daily dosage of at least 2 meq of acid neutralizing capacity, and the folic acid compound or derivative thereof has a total daily dosage of at least 500 mcg.
-
-
25. A method for optimizing absorption of folic acid in an animal, which comprises ingesting:
-
stable chewable dosage form comprising a non-toxic acid neutralizing alkaline compound selected from the group consisting of calcium-based compounds, antacids, aluminum-based compounds, magnesium-based compounds, sodium-based compounds, potassium-based compounds, and mixtures thereof surrounding a folic acid compound or derivative thereof;
wherein the non-toxic acid neutralizing alkaline compound is present in said dosage form in a total daily dosage of at least 2 meq of acid neutralizing capacity, and the folic acid compound or derivative thereof is present in said dosage form in a total daily dosage of at least 450 mcg. - View Dependent Claims (26, 27, 28, 29)
-
-
30. A method for optimizing absorption of folic acid in a pregnant woman, which comprises:
-
stable chewable dosage form comprising a non-toxic acid neutralizing alkaline compound selected from the group consisting of calcium-based compounds, antacids, aluminum-based compounds, magnesium-based compounds, sodium-based compounds, potassium-based compounds, and mixtures thereof surrounding a folic acid compound or derivative thereof;
wherein the non-toxic acid neutralizing alkaline compound is present in said dosage form in a total daily dosage of at least 2 meq of acid neutralizing capacity, and the folic acid compound or derivative thereof is present in said dosage form in a total daily dosage of at least 500 mcg.
-
-
31. A method of optimizing the absorption of folic acid administered to an animal in a nutritional supplement, which comprises:
-
administering at least once during a day to the animal a stable chewable, dissolvable form comprising a folic acid compound or derivative thereof in combination with a non-toxic acid neutralizing alkaline compound;
wherein the total dosage of said folic acid compound or derivative thereof administered during the day is at least 450 mcg, and the total dosage of said non-toxic acid neutralizing alkaline compound administered during the day has at least 2 meq of acid neutralizing capacity. - View Dependent Claims (32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42)
-
-
43. A method of optimizing the absorption of folic acid administered to a pregnant woman in a nutritional supplement, which comprises:
-
administering at least once during a day to the pregnant woman a stable chewable, dissolvable form comprising a folic acid compound or derivative thereof in combination with a non-toxic acid neutralizing alkaline compound;
wherein the total dosage of said folic acid compound or derivative thereof administered during the day is at least 500 mcg, and the total dosage of said non-toxic acid neutralizing alkaline compound administered during the day has at least 2 meq of acid neutralizing capacity.
-
-
44. A method of preventing or treating folic acid deficiency in a pregnant woman, which comprises:
-
administering at least once during a day to the pregnant woman a stable chewable, dissolvable form comprising a folic acid compound or derivative thereof in combination with a non-toxic acid neutralizing alkaline compound;
wherein the total dosage of said folic acid compound or derivative thereof administered during the day is at least 500 mcg, and the total dosage of said non-toxic acid neutralizing alkaline compound administered during the day has at least 2 meq of acid neutralizing capacity.
-
-
45. A method of optimizing the absorption of folic acid administered to an animal in a nutritional supplement, which comprises:
-
administering at least once during a day to the mammal a stable chewable form comprising a folic acid compound or derivative thereof in combination with a non-toxic acid neutralizing alkaline compound selected from the group consisting of calcium-based compounds, antacids, aluminum-based compounds, magnesium-based compounds, sodium-based compounds, potassium-based compounds and mixtures thereof;
wherein the total dosage of said folic acid compound or derivative thereof administered during the day is at least 450 mcg, and the total dosage of said non-toxic acid neutralizing alkaline compound administered during the day has at least 2 meq of acid neutralizing capacity.
-
-
46. A method of optimizing the absorption of folic acid administered to a pregnant woman in a nutritional supplement, which comprises:
-
administering at least once during a day to the pregnant woman a stable chewable form comprising a folic acid compound or derivative thereof in combination with a non-toxic acid neutralizing alkaline compound selected from the group consisting of calcium-based compounds, antacids, aluminum-based compounds, magnesium-based compounds, sodium-based compounds, potassium-based compounds and mixtures thereof;
wherein the total dosage of said folic acid compound or derivative thereof administered during the day is greater than 500 mcg, and the total dosage of said non-toxic acid neutralizing alkaline compound administered during the day has at least 2 meq of acid neutralizing capacity.
-
-
47. A method of preventing or treating folic acid deficiency in a pregnant woman, which comprises:
-
administering at least once during a day to the pregnant woman a stable chewable form comprising a folic acid compound or derivative thereof in combination with a non-toxic acid neutralizing alkaline compound selected from the group consisting of calcium-based compounds, antacids, aluminum-based compounds, magnesium-based compounds, sodium-based compounds, potassium-based compounds and mixtures thereof;
wherein the total dosage of said folic acid compound or derivative thereof administered during the day is at least 500 mcg, and the total dosage of said non-toxic acid neutralizing alkaline compound administered during the day has at least 2 meq of acid neutralizing capacity.
-
-
48. A method of preventing or treating a condition where treatment with folic acid is indicated in an animal, which comprises:
-
administering at least once during a day to the animal a stable chewable, dissolvable from comprising a folic acid compound or derivative thereof in combination with a non-toxic acid neutralizing alkaline compound;
wherein the total dosage of said folic acid compound or derivative thereof administered during the day is at least 450 mcg, and the total dosage of said non-toxic acid neutralizing alkaline compound administered during the day has at least 2 meq of acid neutralizing capacity.
-
Specification